Use and interpretation of rheumatologic tests: A guide for clinicians

Mayo Clinic Proceedings

Volumn 71, Issue 4, 1996, Pages 391-396

  Moder, Kevin G ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; MEDICAL PRACTICE; PRIMARY MEDICAL CARE; REVIEW; RHEUMATIC DISEASE;

EID: 0029874516     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.4.391     Document Type: Review

References (17)

1. Hulley SB, Cummings SR, editors. Designing Clinical Research: An Epidemiologie Approach. Baltimore: Williams & Wilkins, 1988
2. von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323-358
3. Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993; 32:297-301
4. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992; 35:216-218
5. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52:148-159
6. Swaak AJ, Huysen V, Smeenk RJ. Antinuclear antibodies in routine analysis: the relevance of putative clinical associations. Ann Rheum Dis 1993; 52:110-114
7. Wolfe F, Cathey MA, Roberts FK. The latex test revisited: rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum 1991 ; 34:951 -960
8. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? BMJ 1982; 285:606
9. Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N Z J Med 1984; 14:277-278
10. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplastic antibody titre. Lancet 1990; 336:709711
11. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425429
12. Kerr GS, Fleischer TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffrnan GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36:365-371
13. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo ClinProc 1989; 64:28-36
14. Jennette JC, Falk RJ. ANCA-diagnostic markers or pathogenic agents? Bull Rheum Dis 1992; 41:3-6
15. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflam-matory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989; 111:143157
16. Moder KG, Gaffey TA, Matteson EL. Idiopathic inflammatory myopathy of the antisynthetase (Jo-1) type associated with noncaseating granulomas. Arthritis Rheum 1993; 36:1743-1747
17. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991; 70:360-375